PUBLIC CONTRACT · 2021
Aquisição de GUSELCUMAB SC 100MG/1ML SOL INJ CAN e RISANCIZUMAB SC 75MG/0,83ML SOL INJ SER, ao abrigo do CPA 2019/55, para o HFF, para o ano 2021
- Contract value
- €7,641.36
- Signed on
- 6 October 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 8403312PUBLISHED DESCRIPTION
10C0518121
Parties involved
- Place of performance
- Portugal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ABBVIE, Lda · Tax ID 510229050
- Bidder
- Janssen cilag · Tax ID 500189412
Values and timeline
- Contract price
- €7,641.36
- Procedure base price
- €40,625.36
- Total effective price
- Not reported on Portal BASE
- Publication date
- 22 November 2021
- Award date
- 15 September 2021
- Signing date
- 6 October 2021
- Performance period
- 60 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2019/55 - Medicamentos diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5449929
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.